Abstract
Abstract
This study aims to evaluate the 12-month clinical outcomes of drug-coated balloon (DCB) treatment for infrapopliteal chronic limb-threatening ischemia (CLTI) in a real-world setting, and to provide evidence to inform clinical decision-making. Based on the PRIME-WIFI multicenter prospective registry, 538 patients (553 limbs) from 10 centers were consecutively enrolled between December 2020 and June 2023. All patients underwent infrapopliteal DCB angioplasty and were included in the 12-month outcome analysis. The primary endpoint was the freedom from major adverse events (MAE), including major amputation, all-cause mortality, and clinically driven target limb reintervention (CD-TLR). Secondary endpoints included amputation-free survival (AFS), sustained clinical improvement, and quality of life. The Kaplan–Meier method was used to estimate event rates, and Cox regression was applied to identify independent predictors of 12-month MAE. The 12-month MAE-free rate was 75.5%, AFS was 82.2%, major amputation-free rate was 95.9%, all-cause mortality-free rate was 85.7%, and CD-TLR-free rate was 91.4%. 58.4% of limbs showed sustained clinical improvement, with significant wound and infection improvement ( p < 0.001). Multivariate Cox regression revealed that BMI (HR 0.91, p = 0.004) and WIfI stage (HR 1.245, p = 0.042) were independent predictors of MAE. In this single-arm, real-world observational cohort, infrapopliteal DCB treatment was associated with acceptable 12-month clinical outcomes. Trial Registration ClinicalTrials.gov, NCT04710420, registered on January 8, 2021
Direct answer
What can I do from this paper page?
Use this page to scan "Twelve-month outcomes of drug-coated balloon treatment for infrapopliteal chronic limb-threatening ischemia in the PRIME-WIFI study subgroup analysis" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Peripheral Artery Disease Management research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Ren2026Twelve,
title = {Twelve-month outcomes of drug-coated balloon treatment for infrapopliteal chronic limb-threatening ischemia in the PRIME-WIFI study subgroup analysis},
author = {Yiming Ren and Julong Guo and Fan Zhang and Wei Zhang and Ziheng Wu and Zibo Feng and Xin Fang and Qiang Li and Hongfei Sang and Zhenyu Shi and Weihao Shi and Chunshui He and Xixiang Gao and Jianming Guo and Tong Zhu and Hui Zhuang and Ye Meng and Lianrui Guo},
journal = {European journal of medical research},
year = {2026},
doi = {10.1186/s40001-026-04710-4},
url = {https://doi.org/10.1186/s40001-026-04710-4}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Peripheral Artery Disease Management research papers?
Follow Peripheral Artery Disease Management research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Twelve-month outcomes of drug-coated balloon treatment for infrapopliteal chronic limb-threatening ischemia in the PRIME-WIFI study subgroup analysis. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app